Ironwood [IRWD] vs Ani Pharmaceuticals [ANIP] Detailed Stock Comparison

Ironwood Pharmaceuticals Inc.

NASDAQ
Loading...

Ani Pharmaceuticals Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ironwood Pharmaceuticals Inc. wins in 7 metrics, Ani Pharmaceuticals Inc. wins in 12 metrics, with 0 ties. Ani Pharmaceuticals Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ironwood Pharmaceuticals Inc. Ani Pharmaceuticals Inc. Better
P/E Ratio (TTM) 27.13 24.08 Ani Pharmaceuticals Inc.
Price-to-Book Ratio -2.35 3.10 Ani Pharmaceuticals Inc.
Debt-to-Equity Ratio -2.28 116.19 Ani Pharmaceuticals Inc.
PEG Ratio -0.18 -0.07 Ani Pharmaceuticals Inc.
EV/EBITDA 8.67 11.46 Ironwood Pharmaceuticals Inc.
Profit Margin (TTM) 8.11% 8.87% Ani Pharmaceuticals Inc.
Operating Margin (TTM) 13.74% 11.99% Ironwood Pharmaceuticals Inc.
EBITDA Margin (TTM) 13.74% 11.99% Ironwood Pharmaceuticals Inc.
Return on Equity -9.17% 16.16% Ani Pharmaceuticals Inc.
Return on Assets (TTM) 19.85% 3.82% Ironwood Pharmaceuticals Inc.
Free Cash Flow (TTM) $127.01M $150.90M Ani Pharmaceuticals Inc.
1-Year Return 488.71% 30.56% Ironwood Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 2.24 2.06 Ani Pharmaceuticals Inc.
Enterprise Value $1.05B $2.00B Ani Pharmaceuticals Inc.
EV/Revenue Ratio 3.53 2.27 Ani Pharmaceuticals Inc.
Gross Profit Margin (TTM) N/A 59.42% N/A
Revenue per Share (TTM) $2 $44 Ani Pharmaceuticals Inc.
Earnings per Share (Diluted) $0.15 $3.32 Ani Pharmaceuticals Inc.
Beta (Stock Volatility) 0.17 0.44 Ironwood Pharmaceuticals Inc.
Short % of Float 16.61% 19.22% Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc. vs Ani Pharmaceuticals Inc. Stock Performance Analysis

Loading Price Chart...

IRWD
ANIP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ironwood Pharmaceuticals Inc.1.10%12.16%3.07%9.50%2.79%-13.58%
Ani Pharmaceuticals Inc.0.75%2.70%5.49%14.02%0.96%4.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ironwood Pharmaceuticals Inc.488.71%-66.76%-68.86%-65.27%-72.43%-62.79%
Ani Pharmaceuticals Inc.30.56%59.07%147.74%54.58%-9.96%3.13%

Performance & Financial Health Analysis: Ironwood Pharmaceuticals Inc. vs Ani Pharmaceuticals Inc.

MetricIRWDANIP
Market Information
Market Cap i$617.99M$1.78B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,783,732380,535
90 Day Avg. Volume i2,608,537370,618
Last Close$3.69$82.29
52 Week Range$0.62 - $5.78$62.14 - $99.50
% from 52W High-36.16%-17.30%
All-Time High$17.76 (Jul 09, 2018)$450.00 (May 29, 2000)
% from All-Time High-79.22%-81.71%
Growth Metrics
Quarterly Revenue Growth-0.47%0.30%
Quarterly Earnings Growth-0.47%0.30%
Financial Health
Profit Margin (TTM) i0.08%0.09%
Operating Margin (TTM) i0.14%0.12%
Return on Equity (TTM) i-0.09%0.16%
Debt to Equity (MRQ) i-2.28116.19
Cash & Liquidity
Book Value per Share (MRQ)$-1.61$25.81
Cash per Share (MRQ)$1.32$14.12
Operating Cash Flow (TTM) i$127.04M$185.22M
Levered Free Cash Flow (TTM) i$111.57M$119.42M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Ironwood Pharmaceuticals Inc. vs Ani Pharmaceuticals Inc.

MetricIRWD (Apr 24, 2026)ANIP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.1324.08
Forward P/E i2.797.55
PEG Ratio i-0.18-0.07
Price to Sales (TTM) i2.242.06
Price to Book (MRQ) i-2.353.10
Market Capitalization
Market Capitalization i$617.99M$1.78B
Enterprise Value i$1.05B$2.00B
Enterprise Value Metrics
Enterprise to Revenue i3.532.27
Enterprise to EBITDA i8.6711.46
Risk & Other Metrics
Beta i0.170.44
Book Value per Share (MRQ) i$-1.61$25.81

Financial Statements Comparison: Ironwood Pharmaceuticals Inc. vs Ani Pharmaceuticals Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIRWD (2025)ANIP (2025)
Revenue/Sales i296.15M883.37M
Cost of Goods Sold iN/A341.31M
COGS % of Revenue i0.0%38.6%
Gross Profit iN/A542.06M
Gross Margin i0.0%61.4%
Research & Development i95.14M51.66M
Operating Income (EBIT) i118.76M81.23M
Operating Margin i40.1%9.2%
EBITDA i124.91M174.58M
EBITDA Margin i42.2%19.8%
Pre-Tax Income i70.03M95.79M
Pre-Tax Income % of Revenue i23.6%10.8%
Income Tax i46.01M17.45M
Income Tax % of Revenue i15.5%2.0%
Net Income (Profit) i24.02M78.34M
Profit Margin i8.1%8.9%

Balance Sheet & Liquidity Metrics

MetricIRWD (2025)ANIP (2025)
Cash & Equivalents i215.46M285.59M
Total Current Assets i274.18M753.12M
Total Current Assets % of Revenue i92.6%85.3%
Total Current Liabilities i242.22M278.11M
Total Current Liabilities % of Revenue i81.8%31.5%
Long-Term Debt i394.87M599.77M
Long-Term Debt % of Revenue i133.3%67.9%
Total Shareholders Equity i-261.84M540.72M
Retained Earnings i-1.67B-23.10M
Retained Earnings % of Revenue i-565.2%-2.6%
Property, Plant & Equipment i9.34M650,000

Cash Flow Statement Comparison

MetricIRWD (2025)ANIP (2025)
Operating Cash Flow i130.69M139.39M
Operating Cash Flow % of Revenue i44.1%15.8%
Capital Expenditures i-34,000-13.84M
Free Cash Flow i127.01M150.90M
FCF Margin i42.9%17.1%
Debt Repayment i0-10.16M
Common Stock Repurchase iN/A-12.21M

Short Interest & Institutional Ownership Analysis

MetricIRWDANIP
Shares Short i17.90M3.58M
Short Ratio i5.919.94
Short % of Float i16.61%19.22%
Shares Outstanding i163.06M22.49M
Float Shares i125.58M19.34M
% Held by Insiders i3.05%7.37%
% Held by Institutions i92.07%99.81%
% Held by Public i4.88%-7.18%

Dividend Analysis & Yield Comparison: Ironwood Pharmaceuticals Inc. vs Ani Pharmaceuticals Inc.

MetricIRWDANIP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A